Yiheng Capital Lowers stake in Synutra International (SYUT)

Synutra International (SYUT) : Yiheng Capital reduced its stake in Synutra International by 9.21% during the most recent quarter end. The investment management company now holds a total of 406,178 shares of Synutra International which is valued at $1,567,847 after selling 41,216 shares in Synutra International , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Synutra International makes up approximately 0.91% of Yiheng Capital’s portfolio.

Other Hedge Funds, Including , Manufacturers Life Insurance Company The boosted its stake in SYUT in the latest quarter, The investment management firm added 8,922 additional shares and now holds a total of 10,708 shares of Synutra International which is valued at $41,333.Renaissance Technologies boosted its stake in SYUT in the latest quarter, The investment management firm added 4,100 additional shares and now holds a total of 83,100 shares of Synutra International which is valued at $320,766.Blackrock Investment Management boosted its stake in SYUT in the latest quarter, The investment management firm added 11,957 additional shares and now holds a total of 89,597 shares of Synutra International which is valued at $345,844.

Synutra International opened for trading at $3.95 and hit $4.03 on the upside on Thursday, eventually ending the session at $3.94, with a gain of 0.51% or 0.02 points. The heightened volatility saw the trading volume jump to 66,120 shares. Company has a market cap of $223 M.

Synutra International Inc. is an infant formula company in China. The Company is engaged in the production distribution and sale of dairy-based nutritional products under the Shengyuan or Synutra line of brands. The Company operates through three segments: Nutritional Food which includes the sale of powdered infant and adult formula products with brands including Super My Angel and Dutch Cow as well as the sale of prepared foods under the brand of Huiliduo; Nutritional Supplement which includes the production and sale of nutritional supplements such as chondroitin sulfate to third-parties and microencapsulated Docosahexanoic Acid and Arachidonic Acid to the nutritional food segment for use in powdered formula production and Other Business which includes non-core businesses such as ancillary sales of excess or unusable ingredients and materials to industrial customers providing genetic diagnostic services for new born babies and sales of cosmetics to pregnant women.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *